These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 24866832

  • 21. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M, Ramezani A, Obudi A, Bijanzadeh B, Salehipour M, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Peyman GA.
    Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
    [Abstract] [Full Text] [Related]

  • 22. Combination therapy in diabetic macular oedema and retinal vein occlusion--past and present.
    Koss MJ, Naser H, Sener A, Ackermann H, Al-Sarireh F, Singh P, Koch FH.
    Acta Ophthalmol; 2012 Sep; 90(6):580-9. PubMed ID: 20636486
    [Abstract] [Full Text] [Related]

  • 23. Moment of cyst eruption captured by optical coherence tomography in diabetic macular edema.
    Oh JH, Oh J.
    Retina; 2015 Jun; 35(6):1283-4. PubMed ID: 25621946
    [No Abstract] [Full Text] [Related]

  • 24. Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
    Sakai T, Ohkuma Y, Kohno H, Hayashi T, Watanabe A, Tsuneoka H.
    Br J Ophthalmol; 2014 Dec; 98(12):1642-8. PubMed ID: 25053762
    [Abstract] [Full Text] [Related]

  • 25. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
    Lim JW, Lee HK, Shin MC.
    Ophthalmologica; 2012 Dec; 227(2):100-6. PubMed ID: 21997197
    [Abstract] [Full Text] [Related]

  • 26. Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema.
    Sonoda S, Sakamoto T, Yamashita T, Otsuka H, Shirasawa M, Kakiuchi N, Uchino E, Terasaki H, Kawano H.
    Invest Ophthalmol Vis Sci; 2014 Jun 06; 55(6):3979-85. PubMed ID: 24906857
    [Abstract] [Full Text] [Related]

  • 27. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
    Yu SY, Nam DH, Lee DY.
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan 06; 256(1):39-47. PubMed ID: 29030692
    [Abstract] [Full Text] [Related]

  • 28. Initial macular thickness and response to treatment in diabetic macular edema.
    Soheilian M, Ramezani A, Yaseri M, Mirdehghan SA, Obudi A, Bijanzadeh B.
    Retina; 2011 Sep 06; 31(8):1564-73. PubMed ID: 21451442
    [Abstract] [Full Text] [Related]

  • 29. Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema.
    Yalcinbayir O, Gelisken O, Kaderli B, Avci R.
    Ophthalmologica; 2011 Sep 06; 225(4):222-7. PubMed ID: 21389739
    [Abstract] [Full Text] [Related]

  • 30. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M, Ramezani A, Bijanzadeh B, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Tabatabaei H, Peyman GA.
    Retina; 2007 Sep 06; 27(9):1187-95. PubMed ID: 18046223
    [Abstract] [Full Text] [Related]

  • 31. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA, Melo LA, Costa RA, Skaf M, Belfort R, Souza-Filho AA, Farah ME, Kuppermann BD.
    Ophthalmology; 2005 Sep 06; 112(9):1557-63. PubMed ID: 16019075
    [Abstract] [Full Text] [Related]

  • 32. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
    Wang YS, Li X, Wang HY, Zhang ZF, Li MH, Su XN.
    Chin Med J (Engl); 2011 Feb 06; 124(3):352-8. PubMed ID: 21362332
    [Abstract] [Full Text] [Related]

  • 33. Diagnostic and therapeutic challenges.
    Dinç UA, Yenerel NM, Görgün E, Yetik H, Kokame GT, Lim JI.
    Retina; 2009 Feb 06; 29(2):275-9. PubMed ID: 18827730
    [No Abstract] [Full Text] [Related]

  • 34. Refractive changes after pharmacologic resolution of diabetic macular edema.
    Deák GG, Lammer J, Prager S, Mylonas G, Bolz M, Schmidt-Erfurth U, Diabetic Retinopathy Research Group Vienna.
    Ophthalmology; 2014 May 06; 121(5):1054-8. PubMed ID: 24439462
    [Abstract] [Full Text] [Related]

  • 35. Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year results.
    Kriechbaum K, Prager S, Mylonas G, Scholda C, Rainer G, Funk M, Kundi M, Schmidt-Erfurth U, Diabetic Retinopathy Research Group.
    Eye (Lond); 2014 Jan 06; 28(1):9-15; quiz 16. PubMed ID: 24336297
    [Abstract] [Full Text] [Related]

  • 36. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone.
    Sheyman AT, Cohen BZ, Friedman AH, Ackert JM.
    JAMA Ophthalmol; 2013 Jul 06; 131(7):864-9. PubMed ID: 23640384
    [Abstract] [Full Text] [Related]

  • 37. Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis.
    Qi HP, Bi S, Wei SQ, Cui H, Zhao JB.
    Curr Eye Res; 2012 Dec 06; 37(12):1136-47. PubMed ID: 22793880
    [Abstract] [Full Text] [Related]

  • 38. Topical dexamethasone γ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema.
    Ohira A, Hara K, Jóhannesson G, Tanito M, Ásgrímsdóttir GM, Lund SH, Loftsson T, Stefánsson E.
    Acta Ophthalmol; 2015 Nov 06; 93(7):610-5. PubMed ID: 26201996
    [Abstract] [Full Text] [Related]

  • 39. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T, Sawada O, Kakinoki M, Sawada T, Kawamura H, Ohji M.
    Acta Ophthalmol; 2013 Jun 06; 91(4):318-24. PubMed ID: 22132711
    [Abstract] [Full Text] [Related]

  • 40. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
    Fan C, Wang Y, Ji Q, Zhao B, Xie J.
    Curr Eye Res; 2014 Sep 06; 39(9):938-43. PubMed ID: 24635755
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.